The global Virus Filtration Solutions market size is predicted to grow from US$ 8492 million in 2025 to US$ 19160 million in 2031; it is expected to grow at a CAGR of 14.5% from 2025 to 2031.

Virus filtration (VF) is a key step in an overall viral clearance process since it has been demonstrated to effectively clear a wide range of mammalian viruses with a log reduction value (LRV)?>?4. The potential to achieve higher LRV from virus retentive filters has historically been examined using bacteriophage surrogates, which commonly demonstrated a potential of?>?9 LRV when using high titer spikes (e.g. 10(10) PFU/mL). However, as the filter loading increases, one typically experiences significant decreases in performance and LRV.

The major players in global Virus Filtration market include Merck KGaA, Asahi Kasei Medical, Pall Corporation, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Kits and Reagents is the main type, with a share about 40%. Biologicals is the main application, which holds a share about 50%.

Infinity Market Research newest research report, the ?Virus Filtration Solutions Industry Forecast? looks at past sales and reviews total world Virus Filtration Solutions sales in 2024, providing a comprehensive analysis by region and market sector of projected Virus Filtration Solutions sales for 2025 through 2031. With Virus Filtration Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virus Filtration Solutions industry.

This Insight Report provides a comprehensive analysis of the global Virus Filtration Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Virus Filtration Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Virus Filtration Solutions market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virus Filtration Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virus Filtration Solutions.

This report presents a comprehensive overview, market shares, and growth opportunities of Virus Filtration Solutions market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Virus Filtration Systems
    Virus Filtration Kits and Reagents
    Virus Filtration Services

Segmentation by Application:

    Biopharmaceuticals and Biotechnology Companies
    Research Laboratories
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Pall Corporation
    Sartorius AG
    GE Healthcare
    Merck Millipore
    AGILITECH
    Asahi Kasei Medical
    Charles River Laboratories
    Clean Cells
    Danaher Corporation
    Merck KGaA
    Thermo Fisher Scientific